Cerci, Kubra, and Pusem Patir. 2023. “Ruxolitinib As a Therapy Choice for Refractory Pruritus in a Patient With Essential Thrombocythemia With CALR Mutation”. Global Journal of Medical and Clinical Case Reports 10 (1):001-002. https://doi.org/10.17352/2455-5282.000167.